
The study assessed insomnia prevalence in the ADHERE registry, analyzing sleep-related data longitudinally. Patients with no/subthreshold insomnia (ISI < 15) and moderate/severe insomnia (ISI ≥ 15) were compared in terms of outcomes. Mental health conditions were worse in ISI ≥ 15 group. HGNS therapy efficacy and adherence were similar between ISI subgroups, but ESS improvement was greater in ISI ≥ 15 patients. Overall, insomnia and sleepiness scores improved in all patients, especially those with baseline moderate/severe insomnia.
Like
Save
Share